nodes	percent_of_prediction	percent_of_DWPC	metapath
Didanosine—PNP—Daunorubicin—Epirubicin—peripheral nervous system neoplasm	0.00847	0.519	CbGdCrCtD
Didanosine—PNP—Daunorubicin—Doxorubicin—peripheral nervous system neoplasm	0.00784	0.481	CbGdCrCtD
Didanosine—Anaemia—Vincristine—peripheral nervous system neoplasm	0.00127	0.00129	CcSEcCtD
Didanosine—Gastrointestinal pain—Topotecan—peripheral nervous system neoplasm	0.00126	0.00128	CcSEcCtD
Didanosine—Gastrointestinal pain—Tretinoin—peripheral nervous system neoplasm	0.00125	0.00127	CcSEcCtD
Didanosine—Gastrointestinal pain—Isotretinoin—peripheral nervous system neoplasm	0.00125	0.00127	CcSEcCtD
Didanosine—Infection—Dactinomycin—peripheral nervous system neoplasm	0.00124	0.00126	CcSEcCtD
Didanosine—Neuropathy—Doxorubicin—peripheral nervous system neoplasm	0.00124	0.00126	CcSEcCtD
Didanosine—Alopecia—Cisplatin—peripheral nervous system neoplasm	0.00123	0.00125	CcSEcCtD
Didanosine—Leukopenia—Vincristine—peripheral nervous system neoplasm	0.00123	0.00125	CcSEcCtD
Didanosine—Thrombocytopenia—Dactinomycin—peripheral nervous system neoplasm	0.00123	0.00125	CcSEcCtD
Didanosine—Abdominal pain—Topotecan—peripheral nervous system neoplasm	0.00122	0.00124	CcSEcCtD
Didanosine—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.00122	0.00124	CcSEcCtD
Didanosine—Dry eye—Doxorubicin—peripheral nervous system neoplasm	0.00122	0.00124	CcSEcCtD
Didanosine—Myalgia—Alitretinoin—peripheral nervous system neoplasm	0.00121	0.00123	CcSEcCtD
Didanosine—Arthralgia—Alitretinoin—peripheral nervous system neoplasm	0.00121	0.00123	CcSEcCtD
Didanosine—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.00121	0.00123	CcSEcCtD
Didanosine—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.00121	0.00123	CcSEcCtD
Didanosine—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.00121	0.00123	CcSEcCtD
Didanosine—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.00121	0.00123	CcSEcCtD
Didanosine—Discomfort—Alitretinoin—peripheral nervous system neoplasm	0.0012	0.00122	CcSEcCtD
Didanosine—Flatulence—Cisplatin—peripheral nervous system neoplasm	0.00119	0.00121	CcSEcCtD
Didanosine—Anorexia—Dactinomycin—peripheral nervous system neoplasm	0.00119	0.00121	CcSEcCtD
Didanosine—Diabetes mellitus—Epirubicin—peripheral nervous system neoplasm	0.00119	0.00121	CcSEcCtD
Didanosine—Blood alkaline phosphatase increased—Epirubicin—peripheral nervous system neoplasm	0.00119	0.00121	CcSEcCtD
Didanosine—Dry mouth—Alitretinoin—peripheral nervous system neoplasm	0.00118	0.0012	CcSEcCtD
Didanosine—Hepatic function abnormal—Epirubicin—peripheral nervous system neoplasm	0.00118	0.0012	CcSEcCtD
Didanosine—Myalgia—Vincristine—peripheral nervous system neoplasm	0.00117	0.00119	CcSEcCtD
Didanosine—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.00116	0.00118	CcSEcCtD
Didanosine—Infection—Alitretinoin—peripheral nervous system neoplasm	0.00115	0.00117	CcSEcCtD
Didanosine—Hepatic failure—Epirubicin—peripheral nervous system neoplasm	0.00115	0.00117	CcSEcCtD
Didanosine—Chills—Etoposide—peripheral nervous system neoplasm	0.00114	0.00116	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Dactinomycin—peripheral nervous system neoplasm	0.00114	0.00116	CcSEcCtD
Didanosine—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.00114	0.00116	CcSEcCtD
Didanosine—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	0.00114	0.00116	CcSEcCtD
Didanosine—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.00113	0.00115	CcSEcCtD
Didanosine—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.00113	0.00115	CcSEcCtD
Didanosine—Alopecia—Etoposide—peripheral nervous system neoplasm	0.00113	0.00115	CcSEcCtD
Didanosine—Anaemia—Cisplatin—peripheral nervous system neoplasm	0.00112	0.00114	CcSEcCtD
Didanosine—Renal failure acute—Epirubicin—peripheral nervous system neoplasm	0.00112	0.00114	CcSEcCtD
Didanosine—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.00112	0.00114	CcSEcCtD
Didanosine—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.00111	0.00113	CcSEcCtD
Didanosine—Infection—Vincristine—peripheral nervous system neoplasm	0.00111	0.00113	CcSEcCtD
Didanosine—Asthenia—Topotecan—peripheral nervous system neoplasm	0.00111	0.00113	CcSEcCtD
Didanosine—Anorexia—Alitretinoin—peripheral nervous system neoplasm	0.00111	0.00112	CcSEcCtD
Didanosine—Blood alkaline phosphatase increased—Doxorubicin—peripheral nervous system neoplasm	0.0011	0.00112	CcSEcCtD
Didanosine—Diabetes mellitus—Doxorubicin—peripheral nervous system neoplasm	0.0011	0.00112	CcSEcCtD
Didanosine—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.0011	0.00112	CcSEcCtD
Didanosine—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.0011	0.00112	CcSEcCtD
Didanosine—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.0011	0.00111	CcSEcCtD
Didanosine—Hepatic function abnormal—Doxorubicin—peripheral nervous system neoplasm	0.00109	0.00111	CcSEcCtD
Didanosine—Malaise—Cisplatin—peripheral nervous system neoplasm	0.00109	0.00111	CcSEcCtD
Didanosine—Pruritus—Topotecan—peripheral nervous system neoplasm	0.00109	0.00111	CcSEcCtD
Didanosine—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.00109	0.00111	CcSEcCtD
Didanosine—Renal impairment—Epirubicin—peripheral nervous system neoplasm	0.00109	0.0011	CcSEcCtD
Didanosine—Leukopenia—Cisplatin—peripheral nervous system neoplasm	0.00108	0.0011	CcSEcCtD
Didanosine—Asthenia—Melphalan—peripheral nervous system neoplasm	0.00108	0.0011	CcSEcCtD
Didanosine—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.00108	0.0011	CcSEcCtD
Didanosine—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.00108	0.0011	CcSEcCtD
Didanosine—Pain—Dactinomycin—peripheral nervous system neoplasm	0.00107	0.00109	CcSEcCtD
Didanosine—Pruritus—Melphalan—peripheral nervous system neoplasm	0.00107	0.00109	CcSEcCtD
Didanosine—Anaphylactoid reaction—Epirubicin—peripheral nervous system neoplasm	0.00107	0.00109	CcSEcCtD
Didanosine—Anorexia—Vincristine—peripheral nervous system neoplasm	0.00107	0.00108	CcSEcCtD
Didanosine—Hepatic failure—Doxorubicin—peripheral nervous system neoplasm	0.00106	0.00108	CcSEcCtD
Didanosine—Hypoglycaemia—Epirubicin—peripheral nervous system neoplasm	0.00106	0.00108	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.00106	0.00108	CcSEcCtD
Didanosine—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.00106	0.00107	CcSEcCtD
Didanosine—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.00105	0.00107	CcSEcCtD
Didanosine—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.00105	0.00107	CcSEcCtD
Didanosine—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.00104	0.00106	CcSEcCtD
Didanosine—Renal failure acute—Doxorubicin—peripheral nervous system neoplasm	0.00104	0.00105	CcSEcCtD
Didanosine—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.00103	0.00105	CcSEcCtD
Didanosine—Myalgia—Cisplatin—peripheral nervous system neoplasm	0.00103	0.00105	CcSEcCtD
Didanosine—Anaemia—Etoposide—peripheral nervous system neoplasm	0.00103	0.00104	CcSEcCtD
Didanosine—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.00102	0.00104	CcSEcCtD
Didanosine—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.00102	0.00104	CcSEcCtD
Didanosine—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.00102	0.00104	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.00102	0.00104	CcSEcCtD
Didanosine—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.00101	0.00103	CcSEcCtD
Didanosine—Renal impairment—Doxorubicin—peripheral nervous system neoplasm	0.001	0.00102	CcSEcCtD
Didanosine—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.001	0.00102	CcSEcCtD
Didanosine—Malaise—Etoposide—peripheral nervous system neoplasm	0.001	0.00102	CcSEcCtD
Didanosine—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.000994	0.00101	CcSEcCtD
Didanosine—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000993	0.00101	CcSEcCtD
Didanosine—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.00099	0.00101	CcSEcCtD
Didanosine—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.00099	0.00101	CcSEcCtD
Didanosine—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.000989	0.00101	CcSEcCtD
Didanosine—Anaphylactoid reaction—Doxorubicin—peripheral nervous system neoplasm	0.000988	0.001	CcSEcCtD
Didanosine—Infection—Cisplatin—peripheral nervous system neoplasm	0.000983	0.000999	CcSEcCtD
Didanosine—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000982	0.000998	CcSEcCtD
Didanosine—Hypoglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.00098	0.000996	CcSEcCtD
Didanosine—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000974	0.00099	CcSEcCtD
Didanosine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000974	0.00099	CcSEcCtD
Didanosine—Rash—Topotecan—peripheral nervous system neoplasm	0.000974	0.00099	CcSEcCtD
Didanosine—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000973	0.000989	CcSEcCtD
Didanosine—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000972	0.000988	CcSEcCtD
Didanosine—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000968	0.000984	CcSEcCtD
Didanosine—Headache—Topotecan—peripheral nervous system neoplasm	0.000967	0.000983	CcSEcCtD
Didanosine—Rash—Tretinoin—peripheral nervous system neoplasm	0.000966	0.000982	CcSEcCtD
Didanosine—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000966	0.000982	CcSEcCtD
Didanosine—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000965	0.000981	CcSEcCtD
Didanosine—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000965	0.000981	CcSEcCtD
Didanosine—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000961	0.000977	CcSEcCtD
Didanosine—Headache—Tretinoin—peripheral nervous system neoplasm	0.00096	0.000975	CcSEcCtD
Didanosine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00096	0.000975	CcSEcCtD
Didanosine—Pain—Vincristine—peripheral nervous system neoplasm	0.000956	0.000972	CcSEcCtD
Didanosine—Rash—Melphalan—peripheral nervous system neoplasm	0.000953	0.000969	CcSEcCtD
Didanosine—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000952	0.000968	CcSEcCtD
Didanosine—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000949	0.000965	CcSEcCtD
Didanosine—Abdominal pain upper—Epirubicin—peripheral nervous system neoplasm	0.000944	0.000959	CcSEcCtD
Didanosine—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000943	0.000958	CcSEcCtD
Didanosine—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000934	0.000949	CcSEcCtD
Didanosine—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000922	0.000938	CcSEcCtD
Didanosine—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000918	0.000933	CcSEcCtD
Didanosine—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000918	0.000933	CcSEcCtD
Didanosine—Nausea—Topotecan—peripheral nervous system neoplasm	0.000917	0.000932	CcSEcCtD
Didanosine—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000915	0.00093	CcSEcCtD
Didanosine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00091	0.000925	CcSEcCtD
Didanosine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00091	0.000925	CcSEcCtD
Didanosine—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000906	0.000921	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000901	0.000916	CcSEcCtD
Didanosine—Infection—Etoposide—peripheral nervous system neoplasm	0.0009	0.000915	CcSEcCtD
Didanosine—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000898	0.000913	CcSEcCtD
Didanosine—Nausea—Melphalan—peripheral nervous system neoplasm	0.000898	0.000913	CcSEcCtD
Didanosine—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000888	0.000903	CcSEcCtD
Didanosine—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000887	0.000902	CcSEcCtD
Didanosine—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000884	0.000899	CcSEcCtD
Didanosine—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000884	0.000899	CcSEcCtD
Didanosine—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	0.000876	0.00089	CcSEcCtD
Didanosine—Abdominal pain upper—Doxorubicin—peripheral nervous system neoplasm	0.000873	0.000888	CcSEcCtD
Didanosine—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000864	0.000878	CcSEcCtD
Didanosine—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.00086	0.000874	CcSEcCtD
Didanosine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000857	0.000871	CcSEcCtD
Didanosine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000855	0.000869	CcSEcCtD
Didanosine—Pain—Cisplatin—peripheral nervous system neoplasm	0.000846	0.00086	CcSEcCtD
Didanosine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000833	0.000847	CcSEcCtD
Didanosine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000824	0.000838	CcSEcCtD
Didanosine—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000821	0.000835	CcSEcCtD
Didanosine—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000814	0.000827	CcSEcCtD
Didanosine—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	0.00081	0.000824	CcSEcCtD
Didanosine—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000806	0.000819	CcSEcCtD
Didanosine—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000803	0.000816	CcSEcCtD
Didanosine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000796	0.000809	CcSEcCtD
Didanosine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000794	0.000807	CcSEcCtD
Didanosine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000789	0.000802	CcSEcCtD
Didanosine—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000788	0.000801	CcSEcCtD
Didanosine—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000782	0.000795	CcSEcCtD
Didanosine—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000781	0.000794	CcSEcCtD
Didanosine—Pain—Etoposide—peripheral nervous system neoplasm	0.000775	0.000788	CcSEcCtD
Didanosine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000765	0.000778	CcSEcCtD
Didanosine—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000753	0.000766	CcSEcCtD
Didanosine—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000745	0.000758	CcSEcCtD
Didanosine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000744	0.000756	CcSEcCtD
Didanosine—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000743	0.000755	CcSEcCtD
Didanosine—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000741	0.000753	CcSEcCtD
Didanosine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000738	0.00075	CcSEcCtD
Didanosine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000732	0.000744	CcSEcCtD
Didanosine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000731	0.000743	CcSEcCtD
Didanosine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000729	0.000741	CcSEcCtD
Didanosine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000727	0.000739	CcSEcCtD
Didanosine—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000722	0.000734	CcSEcCtD
Didanosine—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000716	0.000728	CcSEcCtD
Didanosine—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000716	0.000728	CcSEcCtD
Didanosine—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000715	0.000727	CcSEcCtD
Didanosine—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000711	0.000723	CcSEcCtD
Didanosine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000711	0.000723	CcSEcCtD
Didanosine—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.00071	0.000721	CcSEcCtD
Didanosine—Rash—Vincristine—peripheral nervous system neoplasm	0.000705	0.000717	CcSEcCtD
Didanosine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000705	0.000716	CcSEcCtD
Didanosine—Headache—Vincristine—peripheral nervous system neoplasm	0.000701	0.000712	CcSEcCtD
Didanosine—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000697	0.000708	CcSEcCtD
Didanosine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000689	0.000701	CcSEcCtD
Didanosine—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000688	0.000699	CcSEcCtD
Didanosine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000677	0.000688	CcSEcCtD
Didanosine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000668	0.000679	CcSEcCtD
Didanosine—Nausea—Vincristine—peripheral nervous system neoplasm	0.000664	0.000675	CcSEcCtD
Didanosine—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000661	0.000672	CcSEcCtD
Didanosine—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000658	0.000669	CcSEcCtD
Didanosine—Asthenia—Etoposide—peripheral nervous system neoplasm	0.00065	0.000661	CcSEcCtD
Didanosine—Chills—Epirubicin—peripheral nervous system neoplasm	0.000641	0.000652	CcSEcCtD
Didanosine—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000641	0.000652	CcSEcCtD
Didanosine—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000632	0.000642	CcSEcCtD
Didanosine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000629	0.000639	CcSEcCtD
Didanosine—Rash—Cisplatin—peripheral nervous system neoplasm	0.000624	0.000634	CcSEcCtD
Didanosine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000623	0.000633	CcSEcCtD
Didanosine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.00062	0.00063	CcSEcCtD
Didanosine—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000613	0.000623	CcSEcCtD
Didanosine—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000594	0.000603	CcSEcCtD
Didanosine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000587	0.000597	CcSEcCtD
Didanosine—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000585	0.000594	CcSEcCtD
Didanosine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000576	0.000586	CcSEcCtD
Didanosine—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000575	0.000585	CcSEcCtD
Didanosine—Rash—Etoposide—peripheral nervous system neoplasm	0.000571	0.000581	CcSEcCtD
Didanosine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000571	0.00058	CcSEcCtD
Didanosine—Headache—Etoposide—peripheral nervous system neoplasm	0.000568	0.000577	CcSEcCtD
Didanosine—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000567	0.000577	CcSEcCtD
Didanosine—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000561	0.000571	CcSEcCtD
Didanosine—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000557	0.000566	CcSEcCtD
Didanosine—Nausea—Etoposide—peripheral nervous system neoplasm	0.000538	0.000547	CcSEcCtD
Didanosine—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000532	0.000541	CcSEcCtD
Didanosine—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.00053	0.000539	CcSEcCtD
Didanosine—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.00053	0.000539	CcSEcCtD
Didanosine—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000523	0.000532	CcSEcCtD
Didanosine—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000519	0.000528	CcSEcCtD
Didanosine—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000518	0.000527	CcSEcCtD
Didanosine—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000515	0.000524	CcSEcCtD
Didanosine—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000508	0.000516	CcSEcCtD
Didanosine—Infection—Epirubicin—peripheral nervous system neoplasm	0.000505	0.000513	CcSEcCtD
Didanosine—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000497	0.000506	CcSEcCtD
Didanosine—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.00049	0.000498	CcSEcCtD
Didanosine—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.00049	0.000498	CcSEcCtD
Didanosine—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000484	0.000492	CcSEcCtD
Didanosine—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000484	0.000492	CcSEcCtD
Didanosine—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000479	0.000487	CcSEcCtD
Didanosine—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.00047	0.000478	CcSEcCtD
Didanosine—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000467	0.000475	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000463	0.00047	CcSEcCtD
Didanosine—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.00046	0.000468	CcSEcCtD
Didanosine—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000456	0.000464	CcSEcCtD
Didanosine—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000448	0.000455	CcSEcCtD
Didanosine—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000447	0.000454	CcSEcCtD
Didanosine—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000442	0.000449	CcSEcCtD
Didanosine—Pain—Epirubicin—peripheral nervous system neoplasm	0.000434	0.000442	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000428	0.000435	CcSEcCtD
Didanosine—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000422	0.000429	CcSEcCtD
Didanosine—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000415	0.000422	CcSEcCtD
Didanosine—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000414	0.000421	CcSEcCtD
Didanosine—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000409	0.000415	CcSEcCtD
Didanosine—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000402	0.000409	CcSEcCtD
Didanosine—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000402	0.000408	CcSEcCtD
Didanosine—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000402	0.000408	CcSEcCtD
Didanosine—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000384	0.000391	CcSEcCtD
Didanosine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000374	0.00038	CcSEcCtD
Didanosine—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000372	0.000378	CcSEcCtD
Didanosine—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000372	0.000378	CcSEcCtD
Didanosine—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000364	0.00037	CcSEcCtD
Didanosine—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000359	0.000365	CcSEcCtD
Didanosine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000348	0.000353	CcSEcCtD
Didanosine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000346	0.000352	CcSEcCtD
Didanosine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000337	0.000343	CcSEcCtD
Didanosine—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000332	0.000338	CcSEcCtD
Didanosine—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000323	0.000328	CcSEcCtD
Didanosine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000322	0.000327	CcSEcCtD
Didanosine—Rash—Epirubicin—peripheral nervous system neoplasm	0.00032	0.000326	CcSEcCtD
Didanosine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.00032	0.000325	CcSEcCtD
Didanosine—Headache—Epirubicin—peripheral nervous system neoplasm	0.000318	0.000323	CcSEcCtD
Didanosine—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000302	0.000307	CcSEcCtD
Didanosine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000299	0.000304	CcSEcCtD
Didanosine—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000296	0.000301	CcSEcCtD
Didanosine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000296	0.000301	CcSEcCtD
Didanosine—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000294	0.000299	CcSEcCtD
Didanosine—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000279	0.000284	CcSEcCtD
